DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Halcion (Triazolam) - Indications and Dosage

 
 



INDICATIONS AND USAGE

HALCION is indicated for the short-term treatment of insomnia (generally 7–10 days). Use for more than 2–3 weeks requires complete reevaluation of the patient (see WARNINGS).

Prescriptions for HALCION should be written for short-term use (7–10 days) and it should not be prescribed in quantities exceeding a 1-month supply.

DOSAGE AND ADMINISTRATION

It is important to individualize the dosage of HALCION Tablets for maximum beneficial effect and to help avoid significant adverse effects.

The recommended dose for most adults is 0.25 mg before retiring. A dose of 0.125 mg may be found to be sufficient for some patients (e.g., low body weight). A dose of 0.5 mg should be used only for exceptional patients who do not respond adequately to a trial of a lower dose since the risk of several adverse reactions increases with the size of the dose administered. A dose of 0.5 mg should not be exceeded.

In geriatric and/or debilitated patients the recommended dosage range is 0.125 mg to 0.25 mg. Therapy should be initiated at 0.125 mg in these groups and the 0.25 mg dose should be used only for exceptional patients who do not respond to a trial of the lower dose. A dose of 0.25 mg should not be exceeded in these patients.

As with all medications, the lowest effective dose should be used.

HOW SUPPLIED

HALCION Tablets are available in the following strengths and package sizes:

0.125 mg (white, elliptical, imprinted HALCION 0.125):
  Reverse numbered
    Unit Dose (100)NDC 0009-0010-32
  10–10 Tablet BottlesNDC 0009-0010-38
  Bottles of 500NDC 0009-0010-11
0.25 mg (powder blue, elliptical, scored, imprinted HALCION 0.25):
  Reverse numbered
    Unit Dose (100)NDC 0009-0017-55
  10–10 Tablet BottlesNDC 0009-0017-59
  Bottles of 500NDC 0009-0017-02

Store at controlled room temperature 20° to 25°C (68° to 77°F) [see USP].

Rx only

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014